综合管理算法用于真实世界的设置中Mycobacterium avium复杂的肺病
Kozo Morimoto1,2,3, Charles L Daley4,5
1Respiratory Disease Center and.
Annals of the American Thoracic Society
|February 11, 2025
概括
由于治疗挑战,管理Mycobacterium avium复杂肺病 (MAC-PD) 是很困难的. 本综述提供了一个新的算法,将非药物疗法和多学科护理整合起来,以获得更好的患者结果.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 医疗管理医疗管理
背景情况:
- 由于治疗疗效有限和不良事件,Mycobacterium avium复杂肺病 (MAC-PD) 的管理具有挑战性.
- 目前的指导方针存在,但现实世界的坚持往往很差,阻止治疗完成.
研究的目的:
- 为MAC-PD提出一个全面的管理算法.
- 整合非抗菌药物管理和多学科方法,以改善患者的治疗结果.
主要方法:
- 审查当前的指导方针和MAC-PD管理中的现实世界挑战.
- 开发一种拟议的算法,包括诊断,疾病表型,非抗微生物策略和量身定制的治疗.
- 强调多学科护理,患者教育和共享决策.
主要成果:
- 由于非特异性症状,诊断延迟很常见;正确的表型 (例如,腔腔病变) 对于治疗选择至关重要.
- 非抗菌管理 (气道清除,营养,潜在疾病管理) 是必不可少的.
- 治疗策略因严重程度而异;非洞腔性疾病最好采用每周三次的治疗方案,而严重/洞腔性形式可能需要每天用氨基糖化物治疗.
结论:
- 提出了一个全面的,多学科的算法来解决MAC-PD管理的挑战.
- 整合非抗微生物治疗和共享决策可以提高治疗坚持和患者的结果.
- 建议在复杂的病例中咨询专家,包括对宏类药物耐药性或需要手术.
更多相关视频
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.1K
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
1.5K
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pneumonia IV: Management
288
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
288
COPD: Management Using Bronchodilators and Corticosteroids
174
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
174
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Cystic Fibrosis: Management
139
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
139
